The Scientific business of Thomson Reuters has announced the early findings of its 2008 Liquent Regulatory Affairs Trends survey. The survey attracted respondents from across the globe representing small, medium and large pharmaceutical companies.
Now in its sixth year, the survey provides a unique insight into emerging and future trends in regulatory product management usage and adoption. Frequently sourced by pharmaceutical journals and publications across the world, this survey has become the premier benchmark of global regulatory submission trends offering timely insights into how pharmaceutical regulatory professionals use technology today and how they plan to harness technology in the future.
There were 137 Regulatory Affairs professionals working in Life Sciences companies across the globe who participated in this survey. The survey concentrates on four key areas - Technology Usage Trends, including both submission publishing software and other desktop software; Document Management System usage; Regulatory Outsourcing trends; and Regulatory trends including use or future use of the electronic Common Technical Document (eCTD).
The demographic make-up of the respondent population is similar to previous years with almost one third working in large pharmaceutical companies and more than a third working in small to medium companies. Another 10 percent of respondents work for biotechnology companies. There were significantly more respondents from Contract Research Organisations (CROs) in 2008 than in 2007. While 68 percent of those surveyed are from the US, majority of the remaining respondents are from Europe - with France, Switzerland, the UK and Germany being the most highly represented.
Full results of the survey are available on request at http://www.liquent.com/2008survey/.
